Functional Restoration of Critically Sized Segmental Defects With Bone Morphogenetic Protein-2 and Heparin Treatment
- 1 November 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Orthopaedics & Related Research
- Vol. 469 (11), 3111-3117
- https://doi.org/10.1007/s11999-011-2012-x
Abstract
Bone defects and fracture nonunions remain a substantial challenge for clinicians. Grafting procedures are limited by insufficient volume and donor site morbidity. As an alternative, biomaterial scaffolds functionalized through incorporation of growth factors such as bone morphogenetic proteins (BMPs) have been developed and appear to regenerate the structure and function of damaged or degenerated skeletal tissue. Our objectives were therefore to determine whether: (1) the addition of heparin alone to collagen scaffolds sufficed to promote bone formation in vivo; (2) collagen-heparin scaffold improved BMP-mediated bone regeneration; and (3) precomplexed heparin and BMP-2 delivered on collagen scaffold could restore long bone biomechanical strength. We created bilateral surgical defects in the femora of 20 rats and filled the defects with PCL scaffolds with one of five treatments: collagen matrix (n = 5), collagen/heparin matrix (n = 7), collagen matrix + BMP-2 (n = 9), collagen/heparin matrix + BMP-2 (n = 9), or collagen matrix + BMP-2/heparin complex (n = 9). Bone formation was observed with radiographs and micro-CT analysis and biomechanical testing was used to assess strength. The addition of heparin alone to collagen did not promote bone ingrowth and the addition of heparin to collagen did not improve BMP-mediated bone regeneration. Delivery of precomplexed BMP-2 and heparin in a collagen matrix resulted in new bone formation with mechanical properties similar to those of intact bone. Our findings suggest delivery of precomplexed BMP-2 and heparin may be an advantageous strategy for treatment of clinically challenging bone defects.Keywords
This publication has 27 references indexed in Scilit:
- Amniotic Fluid Stem Cells Produce Robust Mineral Deposits on Biodegradable ScaffoldsTissue Engineering, Part A, 2009
- Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cellsJournal of Biomedical Science, 2008
- Biomimetic modification of the TiO2/glass composite Ecopore with heparinized collagen and the osteoinductive factor BMP-2Acta Biomaterialia, 2008
- Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term deliveryBiochemical and Biophysical Research Communications, 2008
- Quantitative assessment of scaffold and growth factor‐mediated repair of critically sized bone defectsJournal of Orthopaedic Research, 2007
- Structural Bone Allograft Combined with Genetically Engineered Mesenchymal Stem Cells as a Novel Platform for Bone Tissue EngineeringTissue Engineering, 2007
- Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2Biomaterials, 2006
- The ABCs of BMPsOrthopaedic Nursing, 2005
- Evaluation of recombinant human bone morphogenetic protein‐2 as a bone‐graft substitute in a canine segmental defect modelJournal of Orthopaedic Research, 2000
- Bone Morphogenetic ProteinsProgress in Growth Factor Research, 1989